Researchers Develop Compound 10 to Slow Alzheimer's Disease Progression
The compound prevents GRK2 aggregation, reduces amyloid beta buildup and kept nerve-cell death slower in mouse tests, researchers said.
6 Articles
6 Articles
New drug to slow Alzheimer's development — and more health headlines
Medical Watch Digest for June 8 New drug to slow Alzheimer's development A promising Alzheimer’s treatment in the works. ETH Zurich University molecular pharmacologists developed a compound that slows the progression of the mind robbing disease. Researches have worked on the drug they call Compound-10 for 20 years and in lab studies it increased survival. [...]
New drug could slow the development of Alzheimer's
"Compound 10" is how Ursula Quitterer refers to the chemical compound that her team has developed and that could slow the progression of Alzheimer's disease. Quitterer is a professor of molecular pharmacology at ETH Zurich and has so far tested the active ingredient first in mice, revealing promising effects: The typical death of nerve cells seen in dementia is significantly slower, and the animals survive longer.
Researchers develop compound 10 to slow Alzheimer's disease progression
Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-aging effects.
New drug could slow the development of Alzheimer’s
Researchers from ETH Zurich have developed an active ingredient that slows down the progression of typical Alzheimer’s symptoms in mice. This new substance protects nerve cells and could in future alleviate the suffering of Alzheimer’s patients. The active ingredient also shows anti-ageing effects.
Promising New Drug Shows Potential to Slow Alzheimer’s Progression
In a groundbreaking advancement in Alzheimer’s disease research, a team led by Professor Ursula Quitterer at ETH Zurich has developed a chemical compound that shows remarkable promise in slowing the progression of this debilitating neurodegenerative disorder. Nicknamed “Compound 10,” this molecule targets a novel mechanism implicated in the pathology of Alzheimer’s, providing fresh hope for […]
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
